Effects of Propanidid and Thiopentone on the Acid-Base Status of Babies Delivered by Elective Caesarean Section

The effects of propanidid and thiopentone on the acidbase status of babies delivered by elective Caesarean section have been compared. The only significant difference between the 2 groups was the lower umbilical cord venous blood pCO) levels in the propanidid group. The acid-base status in both these groups of babies was not as good as in those delivered after induction delivery times of less than 6 minutes when thiopentone had been used as the induction agent. The clinical state of the babies in the propanidid group was superior to that in the thiopentone group, and at least equal to that of the group with the short induction-delivery interval.S. Afr. Med. J., 48, 1019 (1974

Low-Temperature Growth of Carbon Nanotube Forests Consisting of Tubes with Narrow Inner Spacing Using Co/Al/Mo Catalyst on Conductive Supports.

We grow dense carbon nanotube forests at 450 °C on Cu support using Co/Al/Mo multilayer catalyst. As a partial barrier layer for the diffusion of Co into Mo, we apply very thin Al layer with the nominal thickness of 0.50 nm between Co and Mo. This Al layer plays an important role in the growth of dense CNT forests, partially preventing the Co-Mo interaction. The forests have an average height of ∼300 nm and a mass density of 1.2 g cm(-3) with tubes exhibiting extremely narrow inner spacing. An ohmic behavior is confirmed between the forest and Cu support with the lowest resistance of ∼8 kΩ. The forest shows a high thermal effusivity of 1840 J s(-0.5) m(-2) K(-1), and a thermal conductivity of 4.0 J s(-1) m(-1) K(-1), suggesting that these forests are useful for heat dissipation devices.This work has been funded by the European projects Technotubes and Grafol. H.S. acknowledges a research fellowship from the Japanese Society for the Promotion of Science (JSPS).This is the accepted manuscript. The final version is available at http://pubs.acs.org/doi/abs/10.1021/acsami.5b04846

The interface between silicon and a high-k oxide

The ability to follow Moore's Law has been the basis of the tremendous success of the semiconductor industry in the past decades. To date, the greatest challenge for device scaling is the required replacement of silicon dioxide-based gate oxides by high-k oxides in transistors. Around 2010 high-k oxides are required to have an atomically defined interface with silicon without any interfacial SiO2 layer. The first clean interface between silicon and a high-K oxide has been demonstrated by McKee et al. Nevertheless, the interfacial structure is still under debate. Here we report on first-principles calculations of the formation of the interface between silicon and SrTiO3 and its atomic structure. Based on insights into how the chemical environment affects the interface, a way to engineer seemingly intangible electrical properties to meet technological requirements is outlined. The interface structure and its chemistry provide guidance for the selection process of other high-k gate oxides and for controlling their growth. Our study also shows that atomic control of the interfacial structure can dramatically improve the electronic properties of the interface. The interface presented here serves as a model for a variety of other interfaces between high-k oxides and silicon.Comment: 10 pages, 2 figures (one color

Fixed-Parameter Tractability of Token Jumping on Planar Graphs

Suppose that we are given two independent sets $I_0$ and $I_r$ of a graph such that $|I_0| = |I_r|$, and imagine that a token is placed on each vertex in $I_0$. The token jumping problem is to determine whether there exists a sequence of independent sets which transforms $I_0$ into $I_r$ so that each independent set in the sequence results from the previous one by moving exactly one token to another vertex. This problem is known to be PSPACE-complete even for planar graphs of maximum degree three, and W[1]-hard for general graphs when parameterized by the number of tokens. In this paper, we present a fixed-parameter algorithm for the token jumping problem on planar graphs, where the parameter is only the number of tokens. Furthermore, the algorithm can be modified so that it finds a shortest sequence for a yes-instance. The same scheme of the algorithms can be applied to a wider class of graphs, $K_{3,t}$-free graphs for any fixed integer $t \ge 3$, and it yields fixed-parameter algorithms

Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis

This is the final version. Available from Public Library of Science via the DOI in this record.Data Availability: All relevant data are within the paper and its Supporting Information files.The deployment of baits containing vaccines or toxins has been used successfully in the management of wildlife populations, including for disease control. Optimisation of deployment strategies seeks to maximise uptake by the targeted population whilst ensuring cost-effectiveness. Tuberculosis (TB) caused by infection with Mycobacterium bovis affects a broad range of mammalian hosts across the globe, including cattle, wildlife and humans. The control of TB in cattle in the UK and Republic of Ireland is hampered by persistent infection in European badgers (Meles meles). The present study aimed to determine the best strategy for maximising uptake of an oral vaccine by wild badgers, using a surrogate novel bait deployed at 40 badger social groups. Baits contained a blood-borne biomarker (Iophenoxic Acid, IPA) in order to measure consumption in badgers subsequently cage trapped at targeted setts. Evidence for the consumption of bait was found in 83% (199/240) of captured badgers. The probability that badgers had consumed at least one bait (IPA >10 μg ml-1) was significantly higher following deployment in spring than in summer. Lower uptake amongst social groups where more badgers were captured, suggested competition for baits. The probability of bait consumption was significantly higher at groups where main and outlier setts were provided with baits than at those where outliers were present but not baited. Badgers captured 10–14 days post bait feeding had significantly higher levels of bait uptake compared to those caught 24–28 days later. Uptake rates did not vary significantly in relation to badger age and whether bait was placed above ground or down setts. This study suggests that high levels of bait uptake can be achieved in wild badger populations and identifies factors influencing the potential success of different deployment strategies. The implications for the development of an oral badger vaccine are discussed.Natural Environment Research Council (NERC)Animal and Plant Health Agency (APHA

Probing cosmic dawn: Ages and star formation histories of candidate z ≥ 9 galaxies

We discuss the spectral energy distributions and physical properties of six galaxies whose photometric redshifts suggest they lie beyond a redshift z ≃ 9. Each was selected on account of a prominent excess seen in the Spitzer/IRAC 4.5 μm band which, for a redshift above z = 9.0, likely indicates the presence of a rest-frame Balmer break and a stellar component that formed earlier than a redshift z ≃ 10. In addition to constraining the earlier star formation activity on the basis of fits using stellar population models with BAGPIPES, we have undertaken the necessary, but challenging, follow-up spectroscopy for each candidate using various combinations of Keck/MOSFIRE, VLT/X-shooter, Gemini/FLAMINGOS2, and ALMA. Based on either Lyman-α or [O III] 88 μm emission, we determine a convincing redshift of z = 8.78 for GN-z-10-3 and a likely redshift of z = 9.28 for the lensed galaxy MACS0416-JD. For GN-z9-1, we conclude the case remains promising for a source beyond z ≃ 9. Together with earlier spectroscopic data for MACS1149-JD1, our analysis of this enlarged sample provides further support for a cosmic star formation history extending beyond redshifts z ≃ 10. We use our best-fitting stellar population models to reconstruct the past rest-frame UV luminosities of our sources and discuss the implications for tracing earlier progenitors of such systems with the James Webb Space Telescope

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer

Background Endocrine resistance is a major hurdle in breast cancer management, and determining the underlying factors driving its growth and aggressive behaviour should vastly improve treatment. Methods Microarray technology (BD Atlas Plastic Human 12 K Microarrays; GeneSifter software), verified by PCR, western blotting and immunocytochemisty, was used to identify genes increased in acquired resistant models to tamoxifen (TamR) or faslodex (FasR) as potential predictive/prognostic markers and new therapeutic targets. Results Alongside known breast cancer genes (β-catenin, PEA3, vitronectin, CD44), two novel genes in endocrine resistance were revealed (the latter never previously described in breast cancer): a securin/cell cycle regulator Pituitary Tumour Transforming Gene-1 (PTTG1), and GDNF receptor-alpha 3 (GFRα3) reported to promote cell survival signalling via RET coreceptor. Altered levels of PTTG1, GFRα3, or their associated family members were observed in further endocrine resistant states, including an additional faslodex resistant model that has progressed to a highly-aggressive state (FasR-Lt) and XMCF-7 cells resistant to oestrogen deprivation. PTTG1 and GFRα3 induction were also implicated in limiting response to anti-EGFR agents currently in breast cancer trials, with GFRα3 ligand (artemin) largely overcoming drug response. mRNA studies in clinical disease revealed PTTG1 associated with lymph node spread, high tumour grade and proliferation, while GFRα3 was enriched in ER-negative tumours and those expressing EGFR, profiles implying roles in clinical resistance and aggressive tumour behaviour. Promisingly, PTTG1 or GFRα3 siRNA knockdown promoted cell kill and inhibited proliferation in the resistant models. Conclusion Cumulatively, these data indicate PTTG1 and GFRα3 may provide useful biomarkers, and perhaps clinically relevant therapeutic targets for multiple resistant states

Brief Communication

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/67313/2/10.1177_088307389801300308.pd

Impacts of removing badgers on localised counts of hedgehogs

This is the final version of the article. Available from Public Library of Science via the DOI in this record.Experimental evidence of the interactions among mammalian predators that eat or compete with one another is rare, due to the ethical and logistical challenges of managing wild populations in a controlled and replicated way. Here, we report on the opportunistic use of a replicated and controlled culling experiment (the Randomised Badger Culling Trial) to investigate the relationship between two sympatric predators: European badgers Meles meles and western European hedgehogs Erinaceus europaeus. In areas of preferred habitat (amenity grassland), counts of hedgehogs more than doubled over a 5-year period from the start of badger culling (from 0.9 ha-1 pre-cull to 2.4 ha-1 post-cull), whereas hedgehog counts did not change where there was no badger culling (0.3-0.3 hedgehogs ha-1). This trial provides experimental evidence for mesopredator release as an outcome of management of a top predator.The study was funded by the United Kingdom Government’s Department for Environment, Food and Rural Affairs (http://www.defra.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Piloting a parent and patient decision aid to support clinical trial decision making in childhood cancer

Objective: Families of a child with cancer can find the decision to enrol in a clinical trial challenging and often misunderstand key concepts that underpin trials. We pilot tested “Delta,” an online and booklet decision aid for parents with a child with cancer, and adolescents with cancer, deciding whether or not to enrol in a clinical trial. Methods: We developed Delta in accordance with the International Patient Decision Aid Standards. We conducted a pre-post pilot with parents with a child, and adolescents, who had enrolled in a paediatric phase III clinical trial for newly diagnosed acute lymphoblastic leukaemia. Parents (n = 37) and adolescents (n = 3) completed a questionnaire before and after using Delta (either the website or booklet, based on their preference). Results: Twenty-three parents (62.2%) and three adolescents (100%) reviewed the Delta website. Parents rated Delta as highly acceptable in regard to being clearly presented, informative, easy to read, useful, visually appealing, and easy to use. All participants reported that they would recommend Delta to others and that it would have been useful when making their decision. Parents' subjective (Mdiff=10.8, SDdiff = 15.69, P <.001) and objective (OR = 2.25, 95% CI, 1.66-3.04; P <.001) clinical trial knowledge increased significantly after reviewing Delta. Conclusions: To our knowledge, Delta is the first reported decision aid, available online and as a booklet, for parents and adolescents deciding whether or not to enrol in a paediatric oncology clinical trial. Our study suggests that Delta is acceptable, feasible, and potentially useful